AI Science Tracker
EN

Integrating Spatial Multi-Omics and Machine Learning to Unravel the Role of PANoptosis in Bladder Cancer Prognosis and Immunotherapy Response

Fudan University Shanghai Cancer Center; Fudan University · 2 Jul 2025 · medicine

Discovery

Integrating Spatial Multi-Omics and Machine Learning to Unravel the Role of PANoptosis in Bladder Cancer Prognosis and Immunotherapy Response

Source check: Source checked. Not independent scientific confirmation.

Finding: Primary article reports multi-omics and ten-ML-algorithm work identifying bladder-cancer PANoptosis subtypes and a prognostic signature. External cohorts support survival associations; immunotherapy response is computationally inferred. This record is limited to the study result and does not establish independent replication or real-world benefit.

Technology: Ten-machine-learning-algorithm panel

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
transcriptomic/spatial data, subtype analysis and ten ML algorithms for the PANoptosis prognostic signature.
Test and result
Primary article reports multi-omics and ten-ML-algorithm work identifying bladder-cancer PANoptosis subtypes and a prognostic signature. External cohorts support survival associations; immunotherapy response is computationally inferred.
Limitation / still unknown
No prospective clinical benefit or broader external validity is established by the documented study.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://doi.org/10.32604/or.2025.064331

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 3/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open in the full catalog for filters, charts and related discoveries. Browse medicine discoveries.

Related catalog entries

Links use documented relationships where available, plus shared catalog context. A shared topic or model family does not establish a scientific dependency.